178 related articles for article (PubMed ID: 26880193)
1. Selecting stage ypT0-1N0 for locally advanced rectal cancer following preoperative chemoradiotherapy: implications for potential candidates of organ-sparing management.
Huang SH; Chi P; Lin HM; Lu XR; Huang YW; Xu ZB; Sun YW; Ye DX; Wang XJ; Wang X
Colorectal Dis; 2016 Oct; 18(10):989-996. PubMed ID: 26880193
[TBL] [Abstract][Full Text] [Related]
2. Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer?
Joye I; Debucquoy A; Fieuws S; Wolthuis A; Sagaert X; D'Hoore A; Haustermans K
Acta Oncol; 2016 Aug; 55(8):1047-52. PubMed ID: 27142064
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of MRI for prediction of candidates for local excision of rectal cancer (ypT0-1N0) after neoadjuvant chemoradiation therapy.
Kim JG; Song KD; Kim SH; Kim HC; Huh JW
J Magn Reson Imaging; 2016 Aug; 44(2):471-7. PubMed ID: 26800999
[TBL] [Abstract][Full Text] [Related]
4. A scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excision.
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX; Yu Q
Oncotarget; 2016 Nov; 7(48):78487-78498. PubMed ID: 27489356
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
6. Comparison of tumor regression grade and clinical stage based on MRI image as a selection criterion for non-radical management after concurrent chemoradiotherapy in locally advanced rectal cancer: a multicenter, retrospective, cross-sectional study.
Yang IJ; Suh JW; Lee J; Ahn HM; Oh HK; Kim DW; Kim MJ; Ryoo SB; Jeong SY; Park KJ; Lee DW; Park SC; Park HC; Oh JH; Kang SB
Int J Colorectal Dis; 2022 Jul; 37(7):1561-1568. PubMed ID: 35648208
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.
Bosch SL; Vermeer TA; West NP; Swellengrebel HA; Marijnen CA; Cats A; Verhoef C; van Lijnschoten I; de Wilt JH; Rutten HJ; Nagtegaal ID
Histopathology; 2016 Nov; 69(5):839-848. PubMed ID: 27270756
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
10. Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation.
Wan J; Liu K; Zhu J; Li G; Zhang Z
Oncotarget; 2015 May; 6(13):11714-22. PubMed ID: 25909169
[TBL] [Abstract][Full Text] [Related]
11. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.
Cui Y; Song M; Tie J; Li S; Wang H; Zhang Y; Geng J; Liu Z; Teng H; Sui X; Zhu X; Cai Y; Li Y; Wang W
J Cancer Res Clin Oncol; 2024 Apr; 150(4):176. PubMed ID: 38575793
[TBL] [Abstract][Full Text] [Related]
13. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
14. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
15. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
[TBL] [Abstract][Full Text] [Related]
16. High nodal positivity rates even in good clinical responders after chemoradiation of rectal cancer: is organ preservation feasible?
Vallam KC; Engineer R; Desouza A; Patil P; Saklani A
Colorectal Dis; 2016 Oct; 18(10):976-982. PubMed ID: 26362820
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.
Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE
Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of pathological good response in locally advanced rectal cancer.
Shao K; Zheng R; Li A; Li X; Xu B
Radiat Oncol; 2021 Jan; 16(1):10. PubMed ID: 33436026
[TBL] [Abstract][Full Text] [Related]
19. Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.
Chung MJ; Nam TK; Jeong JU; Kim SH; Kim K; Jang HS; Jeong BK; Lee JH
Int J Colorectal Dis; 2016 Sep; 31(9):1595-601. PubMed ID: 27464635
[TBL] [Abstract][Full Text] [Related]
20. Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
Rombouts AJM; Hugen N; Verhoeven RHA; Elferink MAG; Poortmans PMP; Nagtegaal ID; de Wilt JHW
Eur J Surg Oncol; 2018 Jul; 44(7):1018-1024. PubMed ID: 29678303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
